Global Viral Vector Manufacturing Market Size, Share, Trends, Demand, Growth and Competitive Analysis 2030
The recent analytical report published by Markntel Advisors (a leading consulting, data analytics, and market research firm), Market comprises a detailed study of critical and major aspects of market dynamics, i.e. market trends, size, forecasts, growth factors, challenges, and competitor landscape.
In-Depth Market Overview of Global
Viral Vector Manufacturing Market (2024-2030):
According
to the latest report, the Global Viral
Vector Manufacturing Market is
estimated to grow at a CAGR of around 19.22% during the forecast period, i.e.,
2024-30. The report demonstrates the prominent factors
propelling the exponential growth of the Global Viral Vector Manufacturing Market.
Key Takeaways: Beneficial for
Stakeholders and Clients
·       
Historic Period: 2019-2022
·       
Base year: 2023
·       
Forecast Years: 2024-2030
·       
CAGR (2024-30): 19.22%
Key Perks: “In
case you missed it, we are currently revising our reports. Click on the below
to get the latest research data with forecasts for the years 2025 to 2030,
including market size, industry trends, and competitive analysis. It wouldn’t
take long for the team to deliver the most recent version of the report.”
Download a sample PDF of this report to gain insights into the complete report structure : https://www.marknteladvisors.com/query/request-sample/viral-vector-manufacturing-market.html
What are the major Driver
the Global Viral Vector Manufacturing Market?
Increased Burden of Genetic Disorders – During the past few years, there has been a significant surge in
the number of genetic disorders globally. Among them, there has been a
significant rise in the number of patients with hemophilia. For instance, the
World Federation of Hemophilia (WFH) reported a global count of approximately
257,146 individuals diagnosed with the condition in 2022. Specifically,
hemophilia A and B cases were recorded at 208,957 and 42,203, respectively.
This surge in instances of hemophilia has resulted in an amplified demand for
gene therapy for treatment purposes. Thus, this demand has consequently driven
the need for viral vectors, essential for delivering gene therapy, thereby
accelerating growth in the Viral Vector Manufacturing Market.
Additionally, the rising
prevalence of other genetic blood disorders, notably sickle-cell disease and
thalassemia, has further fueled market growth. According to the World Health
Organization (WHO), approximately 5% of the global population carries trait
genes for hemoglobin disorders, predominantly sickle-cell disease and
thalassemia. Furthermore, increasing awareness and initiatives by government
and non-governmental organizations aimed at educating the public about these
genetic disorders and facilitating their diagnosis and treatment are
contributing to the increased number of diagnosed patients who require
therapies. 
Global Viral Vector Manufacturing
Market Segmentation
The Global
Viral Vector Manufacturing Market analysis of MarkNtel Advisors explores the
industry by emphasizing the growth parameters and categorizes including
geographical segmentation, to offer a comprehensive understanding of the market
dynamic. The further bifurcations are as follows:
- By Vector Type
- Adenoviral Vector- Market Size &
      Forecast 2019-2030, USD Million
- Adeno-Associated Viral Vector- Market
      Size & Forecast 2019-2030, USD Million
- Lentiviral Vector- Market Size &
      Forecast 2019-2030, USD Million
- Herpes Simplex Viral-Vector- Market
      Size & Forecast 2019-2030, USD Million
- Retroviral Vector- Market Size &
      Forecast 2019-2030, USD Million
- Others (CMV, HSV-1, Vaccina, etc.)-
      Market Size & Forecast 2019-2030, USD Million
- By Application
- Gene Therapy- Market Size &
      Forecast 2019-2030, USD Million
- Cell Therapy- Market Size &
      Forecast 2019-2030, USD Million
- Vaccines- Market Size & Forecast
      2019-2030, USD Million
- Non-Replicating Viral Vector Vaccines-
       Market Size & Forecast 2019-2030, USD Million
- Replicating Viral Vector Vaccines- Market
       Size & Forecast 2019-2030, USD Million
- By Indication
- Genetic Disorders- Market Size &
      Forecast 2019-2030, USD Million
- Hemophilia- Market Size & Forecast
       2019-2030, USD Million
- Sickle Cell Disease- Market Size &
       Forecast 2019-2030, USD Million
- Duchenne muscular dystrophy- Market
       Size & Forecast 2019-2030, USD Million
- Beta-Thalassemia- Market Size &
       Forecast 2019-2030, USD Million
- Spinal Muscular Atrophy (SMA)- Market
       Size & Forecast 2019-2030, USD Million
- Others (inherited retinal disorder,
       cerebral adrenoleukodystrophy (CALD, severe combined immunodeficiency
       due to adenosine deaminase deficiency)-   Market Size &
       Forecast 2019-2030, USD Million
- Cancer- Market Size & Forecast
      2019-2030, USD Million
- Bladder Cancer- Market Size &
       Forecast 2019-2030, USD Million
- Blood Cancer- Market Size &
       Forecast 2019-2030, USD Million
- Head & Neck Cancer- Market Size
       & Forecast 2019-2030, USD Million
- Infectious Diseases- Market Size &
      Forecast 2019-2030, USD Million
- COVID-19- Market Size & Forecast
       2019-2030, USD Million
- Ebola Virus- Market Size &
       Forecast 2019-2030, USD Million
- Malaria- Market Size & Forecast
       2019-2030, USD Million
- By Scale of Operation
- Pre-Clinical- Market Size &
      Forecast 2019-2030, USD Million
- Clinical- Market Size & Forecast
      2019-2030, USD Million
- Commercial- Market Size & Forecast
      2019-2030, USD Million
- By End User
- Biotech Companies- Market Size &
      Forecast 2019-2030, USD Million
- Pharmaceutical Companies- Market Size
      & Forecast 2019-2030, USD Million
- Research Organizations- Market Size
      & Forecast 2019-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
As per the regional aspect, the Global Viral Vector Manufacturing Market is expected to be dominated by the North America by capturing the potential market share.
Explore further
details about this research report- 
https://www.marknteladvisors.com/research-library/viral-vector-manufacturing-market.html
Top
Companies in the Global Viral Vector Manufacturing Market 
Oxford Biomedica PLC, Charles River Laboratories, FUJIFILM
Corporation, Lonza, Merck KgaA, Catalent, Inc., AGC Biologics, Thermo Fisher
Scientific Inc., Vector BioMed, Biovian Oy, ReiThera srl, Curia Global, Inc.,
Aurigene Pharmaceutical Services Ltd., Revvity, etc.
Global Viral
Vector Manufacturing Industry Recent Development
- 2022: Kite received the US Food and Drug Administration (FDA) approval of a viral vector manufacturing facility in Southern California to produce a commercial product.
Why Markntel Advisor Report?
Well-known business
Prospects: Our accurate analysis market research report serves as a treasure
map for discovering potential markets and novel product avenues. Additionally,
it facilitates comparisons of products and services.
Thoughtful Customer
Insights: A market report provides the marketing department with an in-depth
understanding of customer requirements and desires. This information is bound
to enhance products, adjust pricing, and refine advertising strategies.
Empowering Data-Backed
Judgement: Our comprehensive Market research encompasses a wide spectrum of
activities, including precise market sizing, detailed segment analysis,
accurate demand forecasting, competitor identification, and meticulous pricing
trend monitoring. 
Need
personalized insights? Click here to customize this report-
https://www.marknteladvisors.com/query/request-customization/viral-vector-manufacturing-market.html
MarkNtel
Advisors
Call- +1 628 895 8081, +91 120 4278433
Email
- sales@marknteladvisors.com
Corporate
Office:  Office No.109, H-159, Sector 63, Noida, Uttar
Pradesh - 201301, India

.webp) 
Comments
Post a Comment